Page 25 - Cellular Imaging in Regenerative Medicine, Cancer and Osteoarthritis

24. Pool SE, Kam BL, Koning GA, Konijnenberg M, Ten Hagen TL, Breeman WA, et al. [(111)In-DTPA]oc- treotide tumor uptake in GEPNET liver metastases after intra-arterial administration: an overview of preclinical and clinical observations and implications for tumor radiation dose after peptide radionuclide therapy. Cancer Biother Radiopharm. 2014;29(4):179-87.
25. Esser JP, Krenning EP, Teunissen JJM, Kooij PPM, Van Gameren ALH, Bakker WH, et al. Comparison of [177Lu-DOTA0,Tyr3]octreotate and [177Lu-DOTA0,Tyr3]octreotide: which peptide is preferable for PRRT? 2006;33(11):1346-51.
26. Markwalder R, Reubi JC. Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation. Cancer Res. 1999;59(5):1152-9.
27. Maina T dJM, Charalambidis D, et al. [67/68Ga]Sarabesin 3: Preclinical evaluation in GRPR- expressing models - First successful clinical PET/CT imaging of prostate cancer metastases. j Nucl Med. 2013;54.
28. Maina T, Bergsma H, Kulkarni HR, Mueller D, Charalambidis D, Krenning EP, et al. Preclinical and first clinical experience with the gastrin-releasing peptide receptor-antagonist [68Ga]SB3 and PET/CT. 2015.
29. Bakker I FA, Busstra MB et al. PET imaging of prostate cancer using the GRPr-targeting ligand Sarabesin 3 prior to radical prostatectomy [abstract]. Eur J Nucl Med. 2016;43.
30. Bugby SL, Lees JE, Perkins AC. Hybrid intraoperative imaging techniques in radioguided surgery: present clinical applications and future outlook. Clin Transl Imaging. 2017;5(4):323-41.
31. Maina T, Bergsma H, Kulkarni HR, Mueller D, Charalambidis D, Krenning EP, et al. Preclinical and first clinical experience with the gastrin-releasing peptide receptor-antagonist [(6)(8)Ga]SB3 and PET/ CT. Eur J Nucl Med Mol Imaging. 2016;43(5):964-73.
32. Martinez FO, Gordon S, Locati M, Mantovani A. Transcriptional Profiling of the Human Monocyte- to-Macrophage Differentiation and Polarization: New Molecules and Patterns of Gene Expression. The Journal of Immunology. 2006;177(10):7303-11.
33. Italiani P, Mazza EMC, Lucchesi D, Cifola I, Gemelli C, Grande A, et al. Transcriptomic Profiling of the Development of the Inflammatory Response in Human Monocytes In Vitro. 2014;9(2):e87680.
34. Xu W, Zhao X, Daha MR, Van Kooten C. Reversible differentiation of pro- and anti-inflammatory macrophages. 2013;53(3):179-86.
35. Drexhage RC, Knijff EM, Padmos RC, Heul-Nieuwenhuijzen LVD, Beumer W, Versnel MA, et al. The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder. 2010;10(1):59-76.
36. Smith RS. A comprehensive macrophage-T-lymphocyte theory of schizophrenia. 1992;39(3):248- 57.
37. Byrne AJ, Maher TM, Lloyd CM. Pulmonary Macrophages: A New Therapeutic Pathway in Fibrosing Lung Disease? Trends in Molecular Medicine. 2016;22(4):303-16.
38. Bobryshev YV, Ivanova EA, Chistiakov DA, Nikiforov NG, Orekhov AN. Macrophages and Their Role in Atherosclerosis: Pathophysiology and Transcriptome Analysis. 2016;2016:1-13.
39. Moore KJ, Sheedy FJ, Fisher EA. Macrophages in atherosclerosis: a dynamic balance. Nature Reviews Immunology. 2013;13(10):709-21.
40. Bain CC, Mowat AM. Macrophages in intestinal homeostasis and inflammation. Immunological Reviews. 2014;260(1):102-17.
41. Udalova IA, Mantovani A, Feldmann M. Macrophage heterogeneity in the context of rheumatoid arthritis. 2016;12(8):472-85.
42. O’Neill TW, McCabe PS, McBeth J. Update on the epidemiology, risk factors and disease outcomes of osteoarthritis. Best Practice & Research Clinical Rheumatology. 2018;32(2):312-26.
43. Blom AB, van Lent PL, Holthuysen AE, van der Kraan PM, Roth J, van Rooijen N, et al. Synovial lining macrophages mediate osteophyte formation during experimental osteoarthritis. Osteoarthritis Cartilage. 2004;12(8):627-35.
44. Khan I, Saeed K, Khan I. Nanoparticles: Properties, applications and toxicities. Arabian Journal of Chemistry. 2017.
45. Wang EC, Wang AZ. Nanoparticles and their applications in cell and molecular biology. Integr Biol (Camb). 2014;6(1):9-26.
Introduction
23
1